Ernexa Therapeutics (ERNAW) Tax Rate (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 17 years of Tax Rate data on file, last reported at 0.72% in Q1 2026.

• Quarterly Tax Rate rose 82.0% year-over-year to 0.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.81% (up 127.0% YoY) and the FY2025 annual result came in at 0.32%, down 1468.0% from the prior year.
• Tax Rate slipped to 0.72% in Q1 2026, from 3.96% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 3.96% in Q4 2025 to a low of 0.49% in Q3 2025.
• A 5-year average of 0.26% and a median of 0.05% in 2024 frame the typical range for Tax Rate.
• The widest YoY moves for Tax Rate: up 401 bps in 2025, down 44 bps in 2025.
• Tracing ERNAW's Tax Rate over 5 years: stood at 0.2% in 2022, then tumbled by 67 bps to 0.06% in 2023, then sank by 164 bps to 0.04% in 2024, then surged by 9708 bps to 3.96% in 2025, then plunged by 82 bps to 0.72% in 2026.
• The last three Tax Rate figures came in at 0.72% (Q1 2026), 3.96% (Q4 2025), and 0.49% (Q3 2025), per Business Quant data.